| 2023-12-07 | +0.17 % |
|
| 2023-12-06 | -0.11 % |
|
| 2023-12-05 | -1.95 % |
- The article discusses various happenings in the stock market, including the decline of Cigna (CI) stock by 15% in November due to investors' concerns about its merger plans with Humana.
- Cigna (CI) stock went down by -1.95% after rumors emerged that Cigna and Humana are in talks to combine through a stock-and-cash deal, potentially leading to an acquisition of Humana by Cigna. The deal is seen as a move to create a company comparable in size to UnitedHealthcare and CVS/Aetna. The rumors align with Cigna's recent plan to sell its Medicare Advantage business, which experts believe could help facilitate regulatory approval for the deal. However, there may be pushback from regulators, particularly due to the fact that both companies have pharmacy benefit managers (PBMs) and are under investigation for allegedly anti-competitive practices. Despite regulatory challenges, if the deal were to go through, it could give the combined company more leverage in negotiations with providers, potentially driving down costs for customers.
- The article discusses how dealmaking conditions have improved in the banking industry, with executives predicting a better outlook for mergers and acquisitions. Cigna stock (CI) went down -1.95% last night, but the article does not specifically mention why.
|
| 2023-11-30 | |
|
| 2023-11-29 | -8.11 % |
|
| 2023-11-27 | -0.55 % |
|
| 2023-11-24 | -0.16 % |
|
| 2023-11-20 | +0.62 % |
- The article discusses how weight-loss drugs, particularly GLP-1 agonists like Wegovy and Ozempic, have become a hot topic in the healthcare and consumer industry earnings calls, with companies having to respond to the potential impact on their sales. The growing popularity of these drugs, which are effective in treating diabetes and weight loss, has led to increased investor interest. The mention of these drugs in earnings transcripts for the third quarter more than doubled compared to the second quarter. The article also highlights the concerns and reactions from different companies, including major consumer products makers like Hershey and Mondelez, as well as pharmaceutical manufacturers and health insurers. The stock of companies like Eli Lilly, Novo Nordisk, and Cigna have been influenced by the discussion around these drugs. The potential long-term use and impact of these drugs are still being explored.
- The article discusses the impact of weight-loss medications on healthcare and consumer companies, with Cigna (CI) stock experiencing a 0.62% increase. The growing popularity of GLP-1 agonists, such as Eli Lilly's Zepbound and Novo Nordisk's Wegovy, which have proven effective in treating diabetes and weight loss, may be a contributing factor to the stock's rise. However, the long-term impact of these medications and their pricing are still uncertain.
- Cigna (CI) stock went up 0.62% as there is growing investor interest in GLP-1 agonists, a class of drugs used for weight loss and treating diabetes, and analysts have been questioning healthcare companies about their potential impact on sales.
|
| 2023-11-17 | +0.11 % |
|
| 2023-11-16 | -0.26 % |
|
| 2023-11-15 | -2.45 % |
|
| 2023-11-14 | -1.37 % |
|
| 2023-11-13 | +0.31 % |
|
| 2023-11-10 | +1.49 % |
|
| 2023-11-08 | +0.11 % |
|
| 2023-11-07 | -3.85 % |
|
| 2023-11-06 | -1.23 % |
|
| 2023-11-03 | -2.58 % |
|
| 2023-11-02 | +3.06 % |
|
| 2023-11-01 | +0.07 % |
|
| 2023-10-30 | +0.65 % |
|
| 2023-10-27 | -0.32 % |
|
| 2023-10-26 | +0.11 % |
|
| 2023-10-25 | -0.25 % |
|
| 2023-10-24 | +1.19 % |
|
| 2023-10-23 | -1.87 % |
|
| 2023-10-17 | -0.49 % |
|
| 2023-10-16 | +2.31 % |
|
| 2023-10-13 | +3.14 % |
|
| 2023-10-12 | +0.46 % |
|
| 2023-10-11 | +0.92 % |
|
| 2023-10-05 | +0.09 % |
|
| 2023-10-04 | +0.24 % |
|
| 2023-10-03 | -1.09 % |
|
| 2023-10-02 | +0.51 % |
- Cigna (CI) stock went up 0.51% last night. The article discusses the launch of an unbranded biosimilar of AbbVie's Humira by Boehringer Ingelheim, which is priced 81% cheaper than the original drug, and suggests that the lower-cost version may appeal to pharmacy benefit managers (PBMs) looking to add cheaper biosimilars to their formulary.
- The article discusses how Bend Health, a virtual pediatric behavioral care provider, has joined Evernorth Health Services as an in-network benefit, which has led to an increase in Cigna (CI) stock. The partnership allows millions of Cigna Healthcare customers to access Bend Health's coaching, therapy, and psychiatry services, which address mental health concerns and build resilience for kids, teens, and caregivers. This innovative approach to behavioral health support and treatment aligns with the goal of providing care when and where it's needed while personalizing interventions for better outcomes.
|
| 2023-09-29 | -1.46 % |
|
| 2023-09-28 | +0.59 % |
|
| 2023-09-25 | +1.69 % |
|
| 2023-09-19 | -0.25 % |
|
| 2023-09-18 | +0.75 % |
|
| 2023-09-15 | -0.03 % |
|
| 2023-09-14 | -0.67 % |
|
| 2023-09-13 | -0.46 % |
|
| 2023-09-08 | +0.07 % |
|
| 2023-09-05 | +0.75 % |
|
| 2023-09-01 | +0.15 % |
|
| 2023-08-31 | -2.27 % |
|
| 2023-08-29 | +0.03 % |
|
| 2023-08-28 | +0.83 % |
|
| 2023-08-24 | +0.2 % |
|
| 2023-08-23 | +0.63 % |
|
| 2023-08-22 | -0.42 % |
|
| 2023-08-21 | +1.9 % |
|
| 2023-08-18 | +2.03 % |
|
| 2023-08-17 | -6.38 % |
|
| 2023-08-16 | -0.11 % |
|
| 2023-08-15 | -0.19 % |
|
| 2023-08-14 | +0.11 % |
|
| 2023-08-11 | +0.21 % |
|
| 2023-08-10 | +0.2 % |
|
| 2023-08-08 | +0.11 % |
|
| 2023-08-07 | +1.83 % |
|
| 2023-08-04 | -0.37 % |
|
| 2023-08-03 | -3.93 % |
|
| 2023-08-02 | +1.27 % |
|
| 2023-08-01 | +0.18 % |
|
| 2023-07-31 | +1.03 % |
|
| 2023-07-28 | -0.22 % |
|
| 2023-07-27 | +0.71 % |
|
| 2023-07-26 | -1.36 % |
|
| 2023-07-24 | -0.58 % |
|
| 2023-07-19 | +2.75 % |
|
| 2023-07-18 | +1.3 % |
|
| 2023-07-14 | +4.7 % |
|
| 2023-07-13 | +0.51 % |
|
| 2023-07-12 | -4.63 % |
|
| 2023-07-10 | +0.44 % |
|
| 2023-07-07 | -0.67 % |
- The article discusses the 25 US companies with the highest profit margins, including Cigna Group (CI), Walt Disney Company (DIS), UnitedHealth Group, Berkshire Hathaway, Marathon Petroleum Corporation, The Home Depot, United Parcel Service (UPS), NIKE, Exxon Mobil Corporation (XOM), Chevron Corporation, and Tesla Inc. The reason why Cigna (CI) stock went down is not mentioned in the article.
- The article states that Cigna Group (CI) stock went down by 0.67% and this drop was part of a general decline in the stock market, with the S&P 500 and Dow Jones Industrial Average also falling. The reason for the decline in Cigna's stock price is not mentioned in the article.
|
| 2023-07-05 | +0.15 % |
|
| 2023-07-03 | -0.1 % |
|
| 2023-06-29 | +0.91 % |
|
| 2023-06-28 | -0.38 % |
|
| 2023-06-27 | -0.22 % |
|
| 2023-06-26 | +0.57 % |
|
| 2023-06-23 | -0.17 % |
|
| 2023-06-22 | +0.55 % |
|
| 2023-06-21 | +1.4 % |
|
| 2023-06-20 | +0.45 % |
|
| 2023-06-16 | -0.24 % |
|
| 2023-06-14 | -3.11 % |
|
| 2023-06-12 | +0.42 % |
|
| 2023-06-08 | +1.04 % |
|